Epigenomics and immunotherapeutic advances in pediatric brain tumors
Abstract Brain tumors are the leading cause of childhood cancer-related deaths. Similar to adult brain tumors, pediatric brain tumors are classified based on histopathological evaluations. However, pediatric brain tumors are often histologically inconsistent with adult brain tumors. Recent research...
Enregistré dans:
Auteurs principaux: | Malak Abedalthagafi, Nahla Mobark, May Al-Rashed, Musa AlHarbi |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b0ded3fd249f44f186613b5be1f73850 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors
Publié: (2021) -
Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies
par: Hua Zhao, et autres
Publié: (2021) -
Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling
par: Feng Liu, et autres
Publié: (2017) -
Global molecular alterations involving recurrence or progression of pediatric brain tumors
par: Fengju Chen, et autres
Publié: (2022) -
CAR T Cell Therapy’s Potential for Pediatric Brain Tumors
par: Pauline Thomas, et autres
Publié: (2021)